Jill O’Donnell-Tormey, Ph.D.

Chief Executive Officer, Cancer Research Institute

Jill O’Donnell-Tormey, Ph.D. has served as a member of our Board of Directors since May 2022. Dr. O’Donnell-Tormey is the Chief Executive Officer and Director of Scientific Affairs of the Cancer Research Institute (“CRI”), a nonprofit organization dedicated exclusively to advancing immunotherapy to treat, control and cure all cancers. She joined the organization in 1987 and has been Chief Executive Officer since 1993. As a recognized leader and advocate for cancer immunotherapy, Dr. O’Donnell-Tormey has spearheaded programs at CRI designed to identify and advance promising combination immunotherapies as well as facilitate global coordination of clinical research initiatives across academia and industry. Dr. O’Donnell-Tormey serves on the boards of The City University of New York (“CUNY”), Richmond University Medical Center, and the Staten Island Foundation. Dr. O’Donnell-Tormey served as a research associate in the department of medicine at Cornell University Medical College and as a postdoctoral fellow in the laboratory of cellular physiology and immunology at The Rockefeller University. She holds a Doctor of Philosophy in cell biology from the SUNY Downstate Medical Center and earned a B.S. in chemistry from Fairleigh Dickinson University.

5 of 9